New! View global litigation for patent families

WO2009052209A3 - Isolation of stem cells and effective control of contamination - Google Patents

Isolation of stem cells and effective control of contamination

Info

Publication number
WO2009052209A3
WO2009052209A3 PCT/US2008/080039 US2008080039W WO2009052209A3 WO 2009052209 A3 WO2009052209 A3 WO 2009052209A3 US 2008080039 W US2008080039 W US 2008080039W WO 2009052209 A3 WO2009052209 A3 WO 2009052209A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
stem
cells
invention
isolation
relates
Prior art date
Application number
PCT/US2008/080039
Other languages
French (fr)
Other versions
WO2009052209A2 (en )
Inventor
Kathy E Mitchell
Steven M Hoynowski
Original Assignee
Univ Kansas
Kathy E Mitchell
Steven M Hoynowski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0605Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/11Epidermal growth factor [EGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/135Platelet-derived growth factor [PDGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones

Abstract

The invention relates to the improved isolation and culture of stem cells. More particularly the invention relates to a method that provides for increased recovery of sterile and viable stem cells from umbilical cord and other tissue sources where stem cells are not readily dissociated.
PCT/US2008/080039 2007-10-16 2008-10-15 Isolation of stem cells and effective control of contamination WO2009052209A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US98025207 true 2007-10-16 2007-10-16
US60/980,252 2007-10-16

Publications (2)

Publication Number Publication Date
WO2009052209A2 true WO2009052209A2 (en) 2009-04-23
WO2009052209A3 true true WO2009052209A3 (en) 2009-08-13

Family

ID=40568060

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/080039 WO2009052209A3 (en) 2007-10-16 2008-10-15 Isolation of stem cells and effective control of contamination

Country Status (1)

Country Link
WO (1) WO2009052209A3 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248290A1 (en) * 2002-05-31 2004-12-09 Marco Riedel Culture systems for the sterile continuous cultivation of cells
US20050058631A1 (en) * 2003-06-27 2005-03-17 Kihm Anthony J. Postpartum cells derived from placental tissue, and methods of making and using the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248290A1 (en) * 2002-05-31 2004-12-09 Marco Riedel Culture systems for the sterile continuous cultivation of cells
US20050058631A1 (en) * 2003-06-27 2005-03-17 Kihm Anthony J. Postpartum cells derived from placental tissue, and methods of making and using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WEISS, M.L. ET AL.: "'Human Umbilibal Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's Disease.'", STEM CELLS, vol. 24, 2006, pages 781 - 792 *

Also Published As

Publication number Publication date Type
WO2009052209A2 (en) 2009-04-23 application

Similar Documents

Publication Publication Date Title
WO2008112715A3 (en) Novel agents of calcium ion channel modulators
WO2006083394A3 (en) Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
WO2009007852A3 (en) Multipotent/pluripotent cells and methods
WO2010037109A3 (en) Process for accelerated capture of carbon dioxide
WO2007092622A3 (en) Compositions and methods for treating bone
WO2009011139A1 (en) Method for isolation of cell, serum-free culture medium for cell, and method for culture of cell
WO2012019168A3 (en) Engineered nucleic acids and methods of use thereof
WO2011017440A3 (en) Implanting organ ports
WO2007119639A1 (en) Gene encoding lignan-methylating enzyme
WO2012034116A3 (en) Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
WO2011003962A3 (en) Improved gas stripping process for the recovery of butanol from fermentation broths
WO2007109654A3 (en) Docetaxel polymorphs and processes
WO2008085221A3 (en) Therapeutic use of cd31 expressing cells
ES2564892B1 (en) Acylated derivatives of polyphenols and / or carbohydrates, preparation methods and uses thereof
WO2008111430A1 (en) METHOD FOR PRODUCING γδT CELL POPULATION
WO2007049730A1 (en) Cytoplasmic hybrid plant belonging to the genus lactuca and method for production thereof
WO2009033391A1 (en) Method, managing equipment, managed equipment and system for controlling alarm flow
WO2014144761A3 (en) Increasing specificity for rna-guided genome editing
WO2007130560A3 (en) Solvent tolerant microorganisms and methods of isolation
WO2007116322A3 (en) Purification of bacterial antigens
WO2010129467A8 (en) Compounds and methods for inhibition of renin, and indications therefor
WO2007125605A1 (en) Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell
WO2007061848A3 (en) Methods for producing, growing, and preserving listeria vaccine vectors
WO2010148253A3 (en) Formulations for lysosomal enzymes
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08839100

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08839100

Country of ref document: EP

Kind code of ref document: A2